Silverarc Capital Management, LLC Forma Therapeutics Holdings, Inc. Transaction History

Silverarc Capital Management, LLC

  • $402 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 25, 2022
SELL
$5.1 - $10.0 $409,948 - $803,820
-80,382 Reduced 45.99%
94,386 $650,000
Q1 2022

May 13, 2022
BUY
$8.34 - $14.69 $1.46 Million - $2.57 Million
174,768 New
174,768 $1.63 Million
Q3 2021

Nov 15, 2021
SELL
$21.22 - $25.7 $205,388 - $248,750
-9,679 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$22.86 - $30.95 $221,261 - $299,565
9,679 New
9,679 $241,000

Others Institutions Holding FMTX

# of Institutions
2
Shares Held
26.5K
Call Options Held
0
Put Options Held
0
View Full List

About Forma Therapeutics Holdings, Inc.

FMTX Quotes by TradingView
  • Ticker FMTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,860,400
  • Market Cap $958M
  • Description
  • Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobin...
More about FMTX
Track This Portfolio

Track Silverarc Capital Management, LLC Portfolio

Follow Silverarc Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silverarc Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silverarc Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email